Synthetic resin matrix system incorporating healing enhancer

Claim 1

A synthetic resin matrix system for drug storage and extended duration drug release comprising a particulate, hydrophilic, water swellable polymer, and inert, non-toxic water miscible organic solvent, and a hydrogen bonding plasticizer; said polymer selected from the group consisting of a synthetic resin matrix system for drug storage and extended duration drug release comprising a particulate, hydrophilic, water swellable polymer, an inert, non-toxic water miscible organic solvent, and a hydrogen bonding plasticizer, said polymer selected from the group consisting of hydroxy(C 2 - 4 alkyl) methacrylate, hydroxy(C 2 - 4 alkyl) acrylate, hydroxy(C 2 - 4 alkoxyC 2 - 4 alkyl) methacrylate, hydroxy(C 2 - 4 alkoxyC 2 - $ alkyl) acrylate, alkoxy(C 2 - 4 alkoxyC 2 - 4 alkyl) methacrylate, alkoxy(C 2 - 4 alkoxyC 2 - 4 alkyl)acrylate, N-(C 1 - 4 alkyl) acrylamide, N-(C 1 - 4 alkyl) methacrylamide, N,N-di(C 1 - 4 alkyl) acrylamide, N,N-di(C 1 - 4 alkyl) methacrylamide, vicinal-epoxy(C 1 - 4 alkyl) methacrylate, or vicinal-epoxy(C 1 - 4 alkyl) acrylate, said solvent selected from the group consisting of polyethylene glycol or polypropylene glycol having a molecular weight averaging between about 200-2000 gram molecular weight units, and wherein said plasticizer being selected from the group consisting of dimethylsulfoxide, dimethylphthalate, 2,3-butylene carbonate, dimethylformamide, dimethyltetramethylene sulfone, diethylsulfone, methylene glycolate, methylpropyl sulfone, or butyrolactone, with said polymer ranging between about 15%-50% by weight of said matrix system, with said solvent ranging between about 30%-65% by weight of said matrix system, with said plasticizer ranging up to about 20% by weight of said matrix system, and further including a medicament agent for local or systemic therapeutic effects, said medicament agent being a growth factor or healing enhancer.